- Home
- HSCS vs BDRX Comparison
HSCS vs BDRX Comparison
Compare HSCS & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- BDRX
- Stock Information
- Founded
- HSCS 2007
- BDRX 2000
- Country
- HSCS United States
- BDRX United Kingdom
- Employees
- HSCS N/A
- BDRX N/A
- Industry
- HSCS Medical Specialities
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- HSCS Health Care
- BDRX Health Care
- Exchange
- HSCS Nasdaq
- BDRX Nasdaq
- Market Cap
- HSCS 2.8M
- BDRX 2.4M
- IPO Year
- HSCS 2022
- BDRX N/A
- Fundamental
- Price
- HSCS $3.30
- BDRX $1.43
- Analyst Decision
- HSCS Strong Buy
- BDRX
- Analyst Count
- HSCS 2
- BDRX 0
- Target Price
- HSCS $13.00
- BDRX N/A
- AVG Volume (30 Days)
- HSCS 8.7K
- BDRX 1.2M
- Earning Date
- HSCS 03-13-2025
- BDRX 04-21-2025
- Dividend Yield
- HSCS N/A
- BDRX N/A
- EPS Growth
- HSCS N/A
- BDRX N/A
- EPS
- HSCS N/A
- BDRX N/A
- Revenue
- HSCS N/A
- BDRX N/A
- Revenue This Year
- HSCS N/A
- BDRX N/A
- Revenue Next Year
- HSCS N/A
- BDRX N/A
- P/E Ratio
- HSCS N/A
- BDRX N/A
- Revenue Growth
- HSCS 261.17
- BDRX N/A
- 52 Week Low
- HSCS $2.36
- BDRX $1.14
- 52 Week High
- HSCS $13.50
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- HSCS 55.49
- BDRX 38.75
- Support Level
- HSCS $2.97
- BDRX $1.28
- Resistance Level
- HSCS $3.83
- BDRX $1.87
- Average True Range (ATR)
- HSCS 0.28
- BDRX 0.25
- MACD
- HSCS 0.06
- BDRX 0.07
- Stochastic Oscillator
- HSCS 56.20
- BDRX 37.66
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.